Immunity for Health

IfH Symposium: Innovations in Antibody-Based Biologics

11 Jun 2026 | Landmark Building, UZ Brussels, Belgium

Register
Register
Register

Thursday, 11 June 2026 | 15:25 - 15:45

argenx's Immunology Innovation Program - Heleen Dewitte, argenx

Through innovation and fruitful partnership with academia, argenx has built a broad clinical development pipeline of differentiated antibody candidates that show promise in treating a variety of severe autoimmune and neurological disorders. Antibodies can be designed with modifications to their variable and/or constant regions, giving them clinically beneficial properties, such as an extended half-life, enhanced cell killing, clearance of antigens from the bloodstream (“sweeping”), or modulation/ablation of downstream Fc-effector functions.

1 speaker

  • Principle Scientist Discovery

    argenx